Blog

Life Science Leader — Leading Through Adversity: A CEO Roundtable on Drug Development During a Pandemic

Four biopharma CEOs discuss with Rob Wright, chief editor of Life Science Leader, how they are leading their organizations and conducting drug development during the COVID-19 pandemic. Appearing in this video are:

  • Jeremy Levin, DPhil, MB, BChir, CEO of Ovid Therapeutics
  • Gil Van Bokkelen, Ph.D., chairman and CEO of Athersys
  • Rachel King, CEO, GlycoMimetics
  • Ted Love, M.D., President & CEO, Global Blood Therapeutics

Click here to view video from lifescienceleader.com